SafdarAli Amur | Biochemistry | Best Researcher Award

Posted on by ScienceFather

Mr. SafdarAli Amur | Biochemistry | Best Researcher Award

Research Student at Beijing University of Chemical Technology, Beijing, China.

Safdar Ali Amur is a biochemistry professional with extensive experience in research, laboratory management, and quality control. He has contributed to quality assurance in the food industry and led research in drug synthesis, natural products, and nanotechnology. With a strong publication record in international journals, he is committed to applying innovative solutions to real-world challenges. Currently pursuing a PhD in Chemical Engineering & Technology at Beijing University of Chemical Technology, he brings a results-driven approach suited for roles in biotechnology, pharmaceuticals, food, and chemical industries. His diverse expertise bridges academia and industry for impactful scientific advancements.

Publication Profile

Orcid

Academic Background

Safdar Ali Amur is currently pursuing a PhD in Chemical Engineering & Technology at Beijing University of Chemical Technology, focusing on bioactive material encapsulation for antibacterial applications. He holds an M.Phil. in Biochemistry from the University of Sindh, where he researched lipid alterations in cancer patients. His academic journey began with a Bachelor’s in Biochemistry from the same institution. With a strong foundation in natural sciences, chemistry, and biotechnology, he has developed expertise in analytical instrumentation, molecular modeling, and nanotechnology, contributing to his research in drug delivery and biomaterials innovation.

Professional Background

Safdar Ali Amur has a diverse professional background spanning academia, research, and industry. He is currently a PhD student at Beijing University of Chemical Technology, focusing on scientific research and publications. Previously, he served as a Lecturer in Biochemistry at Beachwood Institute of Nursing and as a Medical Technologist & Lab In-charge at Ghazi Pathology Laboratory. His experience includes roles in microbiology, quality control in the food industry, and administrative support at WHO. His multidisciplinary expertise enables him to contribute effectively to biotechnology, pharmaceuticals, and chemical sciences.

Awards and Honors

Safdar Ali Amur has received numerous recognitions, including a participation certificate for the Anatomical Art Gallery at Beachwood Institute of Nursing. He completed a Starter Nutrition Course from The Health Sciences Academy, UK, and an English Typing Speed Certificate from gnDiploma.net. Additionally, he earned an academic internship certificate from the Pakistan Council of Scientific & Industrial Research Laboratories. His contributions to scientific research have been acknowledged through high-impact publications, reflecting his commitment to advancing biochemistry, drug synthesis, and nanotechnology.

Research Focus

Safdar Ali Amur’s research focuses on drug delivery systems, biomaterials, and nanotechnology. He specializes in the encapsulation of bioactive compounds into metal-organic frameworks (MOFs) for antibacterial and therapeutic applications. His work extends to natural product extraction, pharmaceutical analysis, and computational chemistry, including density functional theory (DFT) studies. With a strong background in biochemistry and materials science, he explores innovative solutions for sustainable drug release, molecular docking, and food safety. His contributions aim to enhance drug efficacy and improve health outcomes through cutting-edge biotechnological advancements.

Publication Top Notes

Conclusion

Safdar Ali Amur is a distinguished researcher with a strong background in biochemistry, nanotechnology, and drug synthesis, demonstrated by his extensive publication record in high-impact international journals. His interdisciplinary expertise, spanning microbiology, chemical engineering, and food quality control, highlights his versatility in scientific research. Currently pursuing a Ph.D. at Beijing University of Chemical Technology, he has gained significant international exposure, further enhancing his academic network. His research on drug delivery systems and antibacterial applications underscores the real-world significance of his work. To further solidify his candidacy for the “Best Researcher Award,” he could benefit from additional publications in top-tier journals, increased citations, patents, and collaborations with renowned international research groups. His strong research portfolio, global academic contributions, and laboratory expertise make him a compelling contender for this prestigious recognition.

 

Bagher Seyedalipour | Biochemistry Award | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Bagher Seyedalipour | Biochemistry Award | Best Researcher Award

Biochemistry, University of Mazandaran, Iran

 

Assoc. Prof. Dr. Bagher Seyedalipour is a distinguished biochemist at the University of Mazandaran, specializing in protein engineering and proteomics. With a Ph.D. from Tehran University, he teaches and conducts advanced research on protein structures and gene manipulation techniques, especially using recombinant DNA. His laboratory focuses on creating therapeutic proteins, like luciferase and superoxide dismutase, exploring their functions and effects through site-directed mutagenesis. Dr. Seyedalipour’s work advances understanding of pathogenic mutations, contributing significantly to molecular biology and therapeutic biochemistry. 🔬🧬

 

Publication Profile

Scopus

Orcid

Academic Background

Dr. Bagher Seyedalipour is an accomplished biochemist with a profound dedication to academic research and teaching. He has developed an extensive foundation in the field of biochemistry through his rigorous education and current academic pursuits at the University of Mazandaran.

Education and Qualifications

Dr. Seyedalipour’s academic journey began with a Bachelor of Science in Biology from Shahid Beheshti University, Tehran. He furthered his expertise with a Master’s degree in Biochemistry from Tarbiat Modares University, followed by a Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics at Tehran University. His extensive training equips him with in-depth knowledge across biochemical sciences, particularly in protein engineering and molecular biology.

Teaching and Research Interests

Dr. Seyedalipour teaches courses on Biochemistry, Structure, Metabolism, and Advanced Molecular Biology for undergraduate and graduate students. His laboratory is primarily focused on Enzymology, Protein Engineering, and Proteomics, aiming to characterize and manipulate genes using recombinant DNA technology. His research highlights include the expression and production of therapeutic proteins, such as luciferase, superoxide dismutase, and uricase, where he applies site-directed mutagenesis for mutation analysis and to explore mutation-pathogenicity relationships.

Conclusion

Dr. Bagher Seyedalipour is a strong candidate for the Research for Best Researcher Award. His work in biochemistry, particularly his focus on protein engineering and pathogenic mutation analysis, stands out in its potential impact on therapeutic advancements and our understanding of molecular biology.

Publication Top Notes  

  • 🧬 “Mutation/metal deficiency in the electrostatic loop enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases,” Ashkaran, F., Seyedalipour, B., et al. – BMC Chemistry (2024)
  • 🧬 “Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation,” Mohammadi, S., Seyedalipour, B., et al. – Biochemical Genetics (2024), 1 citation
  • 🧬 “GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran,” Jalalian, E.J., Seyedalipour, B., et al. – Pregnancy Hypertension (2024)s
  • 🧬 “1,4-Diol Hq (TBHQ) vs 1,4-dithiol (TBDT); simulation of safe antioxidant with a lower carcinogenic activity,” Mosavi, S.Z., Seyedalipour, B., et al. – Science Progress (2024)
  • 🧬 “Exploring the anti-amyloid potential of salvianolic acid A against the ALS-associated mutant SOD1,” Waheed, Z.A., Seyedalipour, B., et al. – Molecular Simulation (2024), 1 citation
  • 🧬 “Catharanthine, an anticancer vinca alkaloid: in silico and in vitro analysis of the autophagic system,” Gholami, F., Seyedalipour, B., et al. – Naunyn-Schmiedeberg’s Archives of Pharmacology (2024)
  • 🧬 “Polyphenolic flavonoid compounds as inhibitors of aggregation in FALS-associated D101G SOD1 mutant,” Qassim, H.M., Seyedalipour, B., et al. – Computational Biology and Chemistry (2023), 4 citations
  • 🧬 “Role of charged residues of the “electrostatic loop” of hSOD1 in aggregation under amyloidogenic conditions,” Mavadat, E., Seyedalipour, B., et al. – International Journal of Biological Macromolecules (2023), 6 citations
  • 🧬 “A double point mutation of SOD1 targeting net charge promotes aggregation,” Mavadat, E., Seyedalipour, B., et al. – Biochimica et Biophysica Acta (2023), 5 citations
  • 🧬 “Sensitive determination of urea in luciferin chemiluminescence system,” Nemati, A., Seyedalipour, B., et al. – Chemical Papers (2023), 1 citation